The relatively new and growing application of genetic testing and gene therapy within the realm of eye care has brought to the forefront numerous ethical and legal considerations.  In this course we will discuss ethical considerations relating to genetic testing, primarily data privacy and confidentiality. We will also look at several clinical scenarios that bring up ethical questions. We will speculate on future ethical dilemmas, as researchers are currently using CRISPR technology to develop new gene editing techniques.  Unfortunately, not all these ethical questions have clear answers. To help guide decision making, current recommendations by the American Academy of Ophthalmology's Task Force on Genetic Testing and the American Medical Association will be examined.  Lastly, we will cover current laws that regulate genetic discrimination in the United States.

Course Code:



Rachelle Lin, O.D.



AOA Expiration Date:


Related News

Constant presence: Alliance builds reputation for patient safety advocacy

Founded five years ago, the Health Care Alliance for Patient Safety (HCAPS) is making good on its mission to advocate for patient safety and protect the fundamental doctor-patient relationship. The alliance’s advocacy will be recognized with the AOA’s Apollo Award during a ceremony at the 2023 Optometry’s Meeting® June 21-24.

What defines the value of care we provide?

Health and vision plans have not adapted and grown with the care we deliver but hold back optometry’s momentum.

How to speak the universal language of care

How to create a bilingual and culturally sensitive practice, why it matters to patients and how it can set you apart from the competition.